Elexacaftor/tezacaftor/ivacaftor in an individual with cystic fibrosis caused by a N1303K CFTR variant and infected with Mycobacterium abscessus
Keyword(s):
This report describes a case of a 15-year-old male with cystic fibrosis caused by N1303K and Q493X cystic fibrosis transmembrane conductance regulator (CFTR) protein variants. In this case, CFTR modulators including tezacaftor/ivacaftor and subsequently elexacaftor/tezacaftor/ivacaftor were utilized and resulted in clinical stability and improvement.
2021 ◽
2010 ◽
Vol 8
(6)
◽
pp. 656-668
◽
2005 ◽
Vol 33
(5)
◽
pp. 996
◽
2015 ◽
Vol 43
(5)
◽
pp. 894-900
◽